SEARCH

SEARCH BY CITATION

References

  • Anikienko KA, Bychikhin EA, Reznik VS, Akamsin D, Galyametdinova IV (2008). Compounds with the dioxopyrimidine cycle inhibit cholinesterases from different groups of animals. Chem Biol Interact 175: 286292.
  • Atack JR, Yu QS, Soncrant TT, Brossi A, Rapoport SI (1989). Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases. J Pharmacol Exp Ther 249: 194202.
  • Ben Assayag E, Shenhar-Tsarfaty S, Ofek K, Soreq L, Bova I, Shopin L et al. (2010). Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality. Mol Med 16: 278286.
  • Bon S, Ayon A, Leroy J, Massoulie J (2003). Trimerization domain of the collagen tail of acetylcholinesterase. Neurochem Res 28: 523535.
  • Brenner T, Hamra-Amitay Y, Evron T, Boneva N, Seidman S, Soreq H (2003). The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis. FASEB J 17: 214222.
  • Caldwell JE (2009). Clinical limitations of acetylcholinesterase antagonists. J Crit Care 24: 2128.
  • Chatonnet A, Lockridge O (1989). Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem J 260: 625634.
  • Dawson LJ, Caulfield VL, Stanbury JB, Field AE, Christmas SE, Smith PM (2005). Hydroxychloroquine therapy in patients with primary Sjogren's syndrome may improve salivary gland hypofunction by inhibition of glandular cholinesterase. Rheumatology (Oxford) 44: 449455.
  • Dobbertin A, Hrabovska A, Dembele K, Camp S, Taylor P, Krejci E et al. (2009). Targeting of acetylcholinesterase in neurons in vivo: a dual processing function for the proline-rich membrane anchor subunit and the attachment domain on the catalytic subunit. J Neurosci 29: 45194530.
  • Doležal V, Vyskočil F, Tuček S (1983). Decrease of the spontaneous non-quantal release of acetylcholine from the phrenic nerve in botulinum-poisoned rat diaphragm. Pflugers Arch 397: 319322.
  • Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 8895.
  • Engel AG, Shen XM, Selcen D, Sine SM (2010). What have we learned from the congenital myasthenic syndromes. J Mol Neurosci 40: 143153.
  • Evron T, Geyer BC, Cherni I, Muralidharan M, Kilbourne J, Fletcher SP et al. (2007). Plant-derived human acetylcholinesterase-R provides protection from lethal organophosphate poisoning and its chronic aftermath. FASEB J 21: 29612969.
  • Fellous JM, Sejnowski TJ (2000). Cholinergic induction of oscillations in the hippocampal slice in the slow (0.5–2 Hz), theta (5–12 Hz), and gamma (35–70 Hz) bands. Hippocampus 10: 187197.
  • Feng G, Krejci E, Molgo J, Cunningham JM, Massoulie J, Sanes JR (1999). Genetic analysis of collagen Q: roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function. J Cell Biol 144: 13491360.
  • Giacobini E (2004). Cholinesterase inhibitors: new roles and therapeutic alternatives. Pharmacol Res 50: 433440.
  • Giniatullin RA, Khazipov RN, Oranska TI, Nikolsky EE, Voronin VA, Vyskočil F (1993). The effect of non-quantal acetylcholine release on quantal miniature currents at mouse diaphragm. J Physiol 466: 105114.
  • Giniatullin RA, Talantova MV, Vyskočil F (2001). The role of desensitisation in decay time of miniature endplate currents in frogs Rana ridibunda and Rana temporaria. Neurosci Res 39: 287292.
  • Girard E, Bernard V, Minic J, Chatonnet A, Krejci E, Molgo J (2007). Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice. Life Sci 80: 23802385.
  • Gisiger V, Belisle M, Gardiner PF (1994). Acetylcholinesterase adaptation to voluntary wheel running is proportional to the volume of activity in fast, but not slow, rat hindlimb muscles. Eur J Neurosci 6: 673680.
  • Grassi J, Vigny M, Massoulie J (1982). Molecular forms of acetylcholinesterase in bovine caudate nucleus and superior cervical ganglion: solubility properties and hydrophobic character. J Neurochem 38: 457469.
  • Hasin Y, Avidan N, Bercovich D, Korczyn A, Silman I, Beckmann JS et al. (2004). A paradigm for single nucleotide polymorphism analysis: the case of the acetylcholinesterase gene. Hum Mutat 24: 408416.
  • Inestrosa NC, Perez CA, Simpfendorfer RW (1994). Sensitivity of acetylcholinesterase molecular forms to inhibition by high MgCl2 concentration. Biochim Biophys Acta 1208: 286293.
  • Jevsek M, Mars T, Mis K, Grubic Z (2004). Origin of acetylcholinesterase in the neuromuscular junction formed in the in vitro innervated human muscle. Eur J Neurosci 20: 28652871.
  • Koelle GB, Davis R, Diliberto EJ Jr, Koelle WA (1974). Selective, near-total, irreversible inactivation of peripheral pseudocholinesterase and acetylcholinesterase in cats in vivo. Biochem Pharmacol 23: 175188.
  • Kovyazina IV, Nikolsky EE, Giniatullin RA, Adamek S, Vyskočil F (2003). Dependence of miniature endplate current on kinetic parameters of acetylcholine receptors activation: a model study. Neurochem Res 28: 443448.
  • Kovyazina IV, Petrov KA, Zobov VV, Bukharaeva EA, Nikolsky EE (2004). Effect of tetraalkylammonium derivatives of 6-methyluracil on the endplate potentials of muscles of different functional types. Dokl Biol Sci 399: 458460.
  • Krejci E, Martinez-Pena y Valenzuela I, Ameziane R, Akaaboune M (2006). Acetylcholinesterase dynamics at the neuromuscular junction of live animals. J Biol Chem 281: 1034710354.
  • Kuba K, Tomita T (1971). Effect of prostigmine on the time course of the end-plate potential in the rat diaphragm. J Physiol 213: 533544.
  • Land BR, Harris WV, Salpeter EE, Salpeter MM (1984). Diffusion and binding constants for acetylcholine derived from the falling phase of miniature endplate currents. Proc Natl Acad Sci USA 81: 15941598.
  • Laskowski MB, Dettbarn WD (1979). An electrophysiological analysis of the effects of paraoxon at the neuromuscular junction. J Pharmacol Exp Ther 210: 269274.
  • Legay C (2000). Why so many forms of acetylcholinesterase? Microsc Res Tech 49: 5672.
  • Lenz DE, Yeung D, Smith JR, Sweeney RE, Lumley LA, Cerasoli DM (2007). Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review. Toxicology 233: 3139.
  • Leung KW, Xie HQ, Chen VP, Mok MK, Chu GK, Choi RC et al. (2009). Restricted localization of proline-rich membrane anchor (PRiMA) of globular form acetylcholinesterase at the neuromuscular junctions – contribution and expression from motor neurons. FEBS J 276: 30313042.
  • Liao J, Heider H, Sun MC, Stieger S, Brodbeck U (1991). The monoclonal antibody 2G8 is carbohydrate-specific and distinguishes between different forms of vertebrate cholinesterases. Eur J Biochem 198: 5965.
  • Lupa MT, Tabti N, Thesleff S, Vyskocil F, Yu SP (1986). The nature and origin of calcium-insensitive miniature end-plate potentials at rodent neuromuscular junctions. J Physiol 381: 607618.
  • Masson P, Lockridge O (2010). Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior. Arch Biochem Biophys 494: 107120.
  • Massoulie J (2002). The origin of the molecular diversity and functional anchoring of cholinesterases. Neurosignals 11: 130143.
  • Massoulie J, Perrier N, Noureddine H, Liang D, Bon S (2008). Old and new questions about cholinesterases. Chem Biol Interact 175: 3044.
  • Meshorer E, Toiber D, Zurel D, Sahly I, Dori A, Cagnano E et al. (2004). Combinatorial complexity of 5′ alternative acetylcholinesterase transcripts and protein products. J Biol Chem 279: 2974029751.
  • Minic J, Chatonnet A, Krejci E, Molgo J (2003). Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions. Br J Pharmacol 138: 177187.
  • Nikolsky EE, Oranska TI, Vyskocil F (1992). Non-quantal acetylcholine release after cholinesterase inhibition in vivo. Physiol Res 41: 333334.
  • Perrier AL, Massoulie J, Krejci E (2002). PRiMA: the membrane anchor of acetylcholinesterase in the brain. Neuron 33: 275285.
  • Perrier NA, Kherif S, Perrier AL, Dumas S, Mallet J, Massoulie J (2003). Expression of PRiMA in the mouse brain: membrane anchoring and accumulation of ‘tailed’ acetylcholinesterase. Eur J Neurosci 18: 18371847.
  • Perrier NA, Salani M, Falasca C, Bon S, Augusti-Tocco G, Massoulie J (2005). The readthrough variant of acetylcholinesterase remains very minor after heat shock, organophosphate inhibition and stress, in cell culture and in vivo. J Neurochem 94: 629638.
  • Petrov K, Kovyazina I, Zobov V, Bukharaeva E, Nikolsky EE, Vyskocil F (2009). Different sensitivity of miniature endplate currents in rat external and internal intercostal muscles to the acetylcholinesterase inhibitor C-547 as compared with diaphragm and extensor digitorum longus. Physiol Res 58: 149153.
  • Petrov KA, Kovyazina LV, Zobov VV, Bukharaeva EA, Nikolsky EE, Vyskocil F (2006). Different sensitivity of miniature endplate currents of the rat extensor digitorum longus, soleus and diaphragm muscles to a novel acetylcholinesterase inhibitor C-547. Physiol Res 55: 585589.
  • Podoly E, Shalev DE, Shenhar-Tsarfaty S, Bennett ER, Ben Assayag E, Wilgus H et al. (2009). The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology. J Biol Chem 284: 1717017179.
  • Rotundo RL (1988). Biogenesis of acetylcholinesterase molecular forms in muscle. Evidence for a rapidly turning over, catalytically inactive precursor pool. J Biol Chem 263: 1939819406.
  • Scott LJ, Bacou F, Sanes JR (1988). A synapse-specific carbohydrate at the neuromuscular junction: association with both acetylcholinesterase and a glycolipid. J Neurosci 8: 932944.
  • Shabunova I, Vyskocil F (1982). Postdenervation changes of intracellular potassium and sodium measured by ion selective microelectrodes in rat soleus and extensor digitorum longus muscle fibres. Pflugers Arch 394: 161164.
  • Urazaev AK, Magsumov ST, Poletayev GI, Nikolsky EE, Vyskocil F (1995). Muscle NMDA receptors regulate the resting membrane potential through NO-synthase. Physiol Res 44: 205208.
  • Vyskocil F, Nikolsky E, Edwards C (1983). An analysis of the mechanisms underlying the non-quantal release of acetylcholine at the mouse neuromuscular junction. Neuroscience 9: 429435.
  • Xie HQ, Leung KW, Chen VP, Lau FT, Liu LS, Choi RC et al. (2008). The promoter activity of proline-rich membrane anchor (PRiMA) of globular form acetylcholinesterase in muscle: suppressive roles of myogenesis and innervating nerve. Chem Biol Interact 175: 7982.
  • Younkin SG, Rosenstein C, Collins PL, Rosenberry TL (1982). Cellular localization of the molecular forms of acetylcholinesterase in rat diaphragm. J Biol Chem 257: 1363013637.
  • Zdrazilova P, Stepankova S, Vranova M, Komers K, Komersova A, Cegan A (2006). Kinetics of total enzymatic hydrolysis of acetylcholine and acetylthiocholine. Z Naturforsch [C] 61: 289294.
  • Zobov VV, Petrov KA, Asliamova AA, Beresinskii LA, Akamsin VD, Galiametdinova IV et al. (2005). Selective blockade of locomotor muscles by uracil-containing tetraalkylammonium acetylcholinesterase inhibitors. Dokl Biol Sci 401: 7780.